YOLFTbeta
15

Optipharm.CO.LTD

153710 · KQ · Healthcare / Diagnostics & Research

4,470.00KRW+85.00 (+1.94%)

Price History

Full chart

Market Stats

Previous Close4,385.00
Open4,400.00
Day Range4,315.00 – 4,485.00
52-Week Range4,075.00 – 6,250.00
Volume13.79K
Market Cap65.94B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.11
50-Day Avg4,711.70
200-Day Avg4,953.78

About

Optipharm.CO.,LTD operates as a biomedical solution provider in South Korea. It also engages in animal disease diagnosis, animal medicine, bacteriophage, Medipig, xenogenic organs, VLP vaccines, xenotransplantation, and other optipharm products, as well as veterinary drug for feed additives and laboratory animal Medipig business. The company was formerly known as Optiparm Solution Co., Ltd. and changed its name to Optipharm.CO.,LTD in 2012. Optipharm.CO.,LTD was founded in 2000 and is based in Cheongju, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • Employees0
  • Headquarters63, Osongsaengmyeong 6-ro, Cheongju, South Korea, 361370, Korea
  • Websitehttps://www.optipharm.co.kr

Financials

Income Statement

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue11.42B14.38B13.86B13.96B13.65B13.05B14.26B16.01B17.37B19.64B22.34B
Growth (%)-+25.83%-3.61%+0.73%-2.19%-4.45%+9.29%+12.27%+8.52%+13.03%+13.79%
Cost of Revenue8.00B9.79B9.51B8.44B9.15B9.54B10.52B12.29B13.18B14.74B16.76B
Gross Profit3.43B4.59B4.35B5.52B4.50B3.51B3.74B3.72B4.20B4.90B5.59B
Gross Margin29.98%31.91%31.37%39.55%32.97%26.90%26.22%23.22%24.16%24.94%25.02%
Operating Expense5.30B4.57B5.98B6.22B5.69B6.96B8.24B7.09B6.83B7.35B8.00B
Operating Income-1.88B20.06M-1.63B-696.41M-1.19B-3.45B-4.50B-3.38B-2.63B-2.45B-2.41B
Operating Margin-16.42%0.14%-11.77%-4.99%-8.72%-26.47%-31.59%-21.10%-15.14%-12.49%-10.80%
EBITDA--------570.65M-526.14M-198.06M-321.03M
EBITDA Margin--------3.56%-3.03%-1.01%-1.44%
Net Income-2.21B-347.97M-1.57B-604.46M-655.33M-2.35B-3.08B-2.04B-2.44B-2.36B-2.50B
Net Income Margin-19.34%-2.42%-11.31%-4.33%-4.80%-18.03%-21.60%-12.77%-14.03%-12.00%-11.18%
R&D317.54M1.29B1.71B1.98B2.17B3.67B5.02B3.82B2.95B2.80B2.82B
R&D as % of Total Revenue2.78%8.95%12.34%14.22%15.88%28.13%35.22%23.87%16.96%14.27%12.63%
Interest Expense0000146.04M108.33M173.78M353.51M477.34M544.33M504.07M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%1.07%0.83%1.22%2.21%2.75%2.77%2.26%

Balance Sheet

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets17.41B20.58B19.84B42.64B41.72B41.32B41.17B41.18B39.28B43.32B40.77B
Total Liabilities13.12B7.08B7.06B7.20B6.11B7.54B10.21B12.17B14.13B15.98B15.37B
Total Equity4.30B13.50B12.79B35.44B35.61B33.78B30.96B29.01B25.14B27.34B25.40B
Cash614.55M4.02B3.30B25.92B25.15B21.92B678.08M553.86M2.25B3.62B2.28B
Total Debt----3.53B------
Net Debt-------1.90B7.36B7.13B8.03B

Cash Flow

Currency: KRW2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-751.51M861.36M260.86M1.20B447.47M-1.62B-1.97B-2.43B-1.72B-595.50M-1.55B
Investing Cash Flow113.06M20.31M-657.80M-330.34M-5.96B-3.96B-7.39B-1.94B-3.59B1.02B-
Financing Cash Flow1.05B2.65B-360.00M22.02B-583.98M1.11B1.82B1.76B1.99B942.99M-
Capital Expenditure139.62M391.95M670.33M202.91M626.46M890.76M757.44M4.60B1.74B1.74B2.54B
Free Cash Flow------2.57B-2.73B-7.04B-3.46B-2.33B-4.10B
FCF to OCF-----159.05%138.46%289.15%200.84%391.55%263.68%

Earnings

Report DateMar 11, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Mar 9, 2020May 16, 2020Aug 8, 2020Nov 15, 2020Mar 8, 2021May 14, 2021Aug 13, 2021Nov 12, 2021Mar 16, 2022Mar 31, 2022Jun 30, 2022Sep 30, 2022Mar 17, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------
EPS Actual-12.63-12.230.34-12.28-21.54-24.87-49.07-44.42-44.86-83.00-71.00-60.002.21-62.71-43.43-43.9210.28-62.42-45.62-48.43-9.64-56.69-52.45-35.88-15.62-77.60-32.06-37.30-23.40-51.39-14.79
Surprise-------------------------------
TimingAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-market------------------

Key Statistics & Ratios

Market Cap65.94B
Enterprise Value67.94B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.80
Price / Book2.73
Revenue (TTM)23.59B
Gross Profit (TTM)5.82B
EBITDA-89.92M
Profit Margin-7.89%
Operating Margin-3.13%
Return on Equity-7.35%
Return on Assets-2.67%
Shares Outstanding14.67M
Shares Float8.59M
Beta0.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%